3-Hydroxy-N-Methyl-3-Phenyl-Propylamine Salt Formation: Trace Oxidation Byproducts & Color Shift Control
Decoding Trace Oxidation Byproducts in 3-Hydroxy-N-Methyl-3-Phenyl-Propylamine: Impact on Downstream Salt Color Shift
In the synthesis of fluoxetine hydrochloride, the quality of the penultimate intermediate, 3-Hydroxy-N-Methyl-3-Phenyl-Propylamine (also known as 3-(Methylamino)-1-phenylpropan-1-ol or alpha-[2-(Methylamino)ethyl]benzyl Alcohol), is paramount. A recurring challenge for quality assurance managers is the subtle but impactful color shift observed in the final salt form, often traced back to trace oxidation byproducts in this amino alcohol. As a pharmaceutical intermediate, its purity directly influences the efficiency of the subsequent etherification step and the final active pharmaceutical ingredient (API) appearance.
From our field experience, the primary culprit is the formation of amino-ketone derivatives via oxidative degradation of the benzylic alcohol group. This degradation is accelerated by exposure to oxygen, elevated temperatures, and trace metal contaminants. Even at levels below 0.1%, these oxidized species can impart a yellow to brown tint upon salt formation with hydrochloric acid, deviating from the expected white to off-white crystalline powder. This is not merely a cosmetic issue; it can indicate a compromised synthesis route and may correlate with other purity deviations. For procurement leads seeking a reliable global manufacturer, understanding these non-standard parameters is critical. For instance, we've observed that viscosity shifts at sub-zero temperatures during winter transit can exacerbate localized oxidation if the material is not properly inerted, a nuance often overlooked in standard specifications.
When evaluating a drop-in replacement for Aldrich-463477, it's essential to look beyond the standard certificate of analysis. Our drop-in replacement for Aldrich-463477: 3-Hydroxy-N-Methyl-3-Phenyl-Propylamine is manufactured under strict atmospheric controls to minimize oxidation from the start. The goal is to provide a product that not only matches the canonical specifications but also delivers superior performance in sensitive downstream processes, ensuring batch-to-batch consistency for acid titration and crystallization.
COA Parameter Deep Dive: Standard vs. Ultra-Low Oxidation Grades for Acid-Salt Crystallization Control
To address the color shift issue, we offer two distinct grades of 3-Hydroxy-N-Methyl-3-Phenyl-Propylamine, each tailored to different process sensitivities. The table below compares the critical parameters that influence salt formation and crystallization behavior.
| Parameter | Standard Grade | Ultra-Low Oxidation Grade |
|---|---|---|
| Assay (GC, %) | ≥99.0 | ≥99.5 |
| Water Content (KF, %) | ≤0.5 | ≤0.3 |
| APHA Color (10% in Methanol) | ≤50 | ≤20 |
| Oxidation Byproducts (HPLC, Area %) | ≤0.5 | ≤0.1 |
| Residual Solvents (GC-HS) | Complies with USP <467> | Complies with USP <467>, with enhanced control on Class 2 solvents |
The Ultra-Low Oxidation Grade is specifically engineered for processes where the acid-salt crystallization is highly sensitive to nucleating impurities. Even trace amounts of oxidized species can act as crystal habit modifiers, leading to inconsistent particle size distribution and filtration challenges. By controlling the oxidation byproducts to ≤0.1% (as measured by a validated HPLC method), we ensure a robust and predictable crystallization outcome. This grade is particularly recommended for custom synthesis projects requiring the highest industrial purity.
It's important to note that the APHA color test, while indicative, does not always correlate linearly with oxidation byproduct levels. We have observed batches with APHA <50 that still exhibited a slight color shift upon salt formation due to specific chromophoric impurities. Therefore, our Ultra-Low Oxidation Grade includes a proprietary stress test that simulates the salt formation conditions to guarantee color stability. Please refer to the batch-specific COA for exact values, as these are monitored on a per-lot basis.
Water Content ≤0.5%: The Critical Lever for Nucleation Rate Consistency in Fluoxetine Intermediate Processing
Water content in 3-Hydroxy-N-Methyl-3-Phenyl-Propylamine is a critical quality attribute that directly impacts the kinetics of the subsequent etherification reaction with 1-chloro-4-trifluoromethylbenzene. In the presence of a strong base, water can lead to hydrolysis of the aryl chloride, reducing yield and introducing impurities. More subtly, water acts as a nucleation inhibitor in the crystallization of fluoxetine hydrochloride. Even at levels below 0.5%, water can widen the metastable zone width, leading to unpredictable nucleation rates and potential oiling out instead of controlled crystallization.
Our manufacturing process ensures a water content consistently ≤0.5% (and ≤0.3% for the Ultra-Low Oxidation Grade) through azeotropic drying and rigorous in-process controls. This tight specification is a key differentiator when sourcing a high purity intermediate. For procurement managers, this translates to a more robust and scalable process, reducing the risk of batch failures and rework. The bulk price advantage of our product is realized not just in the per-kilogram cost but in the overall process economics, where consistent quality minimizes downstream processing costs.
Furthermore, we have observed that in large-scale reactions, the exothermic nature of the etherification can cause localized temperature spikes. If the water content is not adequately controlled, these spikes can lead to accelerated degradation and color formation. Our rigorous control of water content, combined with the low oxidation profile, provides a dual safeguard against such process deviations. This is the kind of hands-on field knowledge that informs our quality by design approach.
Bulk Packaging and Handling Protocols to Preserve Ultra-Low Oxidation Specifications During Global Logistics
Maintaining the integrity of 3-Hydroxy-N-Methyl-3-Phenyl-Propylamine from the manufacturing site to the end-user's reactor is a logistical challenge that requires meticulous attention. The compound is sensitive to oxygen and moisture, and its physical state can complicate handling. As detailed in our article on bulk 3-Hydroxy-N-Methyl-3-Phenyl-Propylamine transit: managing 64°C phase transition & warehouse staging, the material has a melting point around 64°C, which means it can solidify during transit in colder climates or if not properly staged in temperature-controlled warehouses.
To preserve the ultra-low oxidation specifications, we employ the following packaging and handling protocols:
- Packaging: The product is packaged under a nitrogen blanket in 210L steel drums with internal epoxy phenolic lining to prevent metal contamination. For larger quantities, IBC totes with nitrogen headspace are available.
- Inert Atmosphere: Each container is sealed with a nitrogen purge to maintain an oxygen-free environment during storage and transit.
- Temperature Control: During winter months, insulated blankets and, if necessary, temperature-controlled containers are used to prevent solidification and the associated risk of localized oxidation due to phase changes.
- Handling: Upon receipt, we recommend that customers store the drums in a dry, cool area (15-25°C) and re-blanket with nitrogen after each use. If the material has solidified, gentle warming to 30-40°C with agitation is advised before sampling to ensure homogeneity.
These protocols are not mere suggestions but are integral to our quality assurance commitment. We understand that for a pharmaceutical intermediate, the supply chain is an extension of the manufacturing process. Our logistics team works closely with clients to ensure that the product arrives in the same pristine condition as when it left our facility, ready for immediate use in their manufacturing process.
Frequently Asked Questions
What HPLC method is recommended for identifying oxidation impurities in 3-Hydroxy-N-Methyl-3-Phenyl-Propylamine?
We recommend a reverse-phase HPLC method using a C18 column with UV detection at 254 nm. A gradient of acetonitrile and phosphate buffer (pH 3.0) effectively separates the main peak from common oxidation byproducts, including the corresponding ketone derivative. Our COA provides relative retention times for these impurities. For exact method parameters, please contact our technical support team.
What are the acceptable APHA color limits for the salt intermediate derived from this amino alcohol?
For fluoxetine hydrochloride, the typical acceptance criterion is an APHA color ≤50 for a 10% solution in methanol. However, for applications requiring a pure white crystalline product, we recommend using our Ultra-Low Oxidation Grade, which consistently yields a salt with APHA ≤20. It's important to note that the color can be influenced by the salt formation conditions, so we advise performing a small-scale stress test.
How do you ensure batch-to-batch consistency for acid titration assays?
We employ a validated non-aqueous titration method with perchloric acid to determine the assay of the amino alcohol. Our statistical process control charts monitor the titration results across batches, with a target Cpk >1.33. Additionally, we provide a comprehensive COA with each shipment, detailing the assay, water content, and impurity profile. For clients requiring even tighter specifications, we offer a custom synthesis service with agreed-upon limits.
What is the CAS number of 1 methyl 3 phenylpropylamine?
The CAS number for 1-methyl-3-phenylpropylamine is 22374-89-6. Please note that this is a different compound from 3-Hydroxy-N-Methyl-3-Phenyl-Propylamine (CAS 42142-52-9), which is the subject of this article. The latter is a hydroxylated derivative used as a key intermediate in fluoxetine synthesis.
Sourcing and Technical Support
At NINGBO INNO PHARMCHEM CO.,LTD., we are committed to providing not just chemicals, but solutions that enhance your process efficiency and product quality. Our 3-Hydroxy-N-Methyl-3-Phenyl-Propylamine is manufactured to the highest standards, with a focus on controlling the subtle parameters that matter most in sensitive pharmaceutical syntheses. Whether you need a standard grade for cost-effective production or an ultra-low oxidation grade for critical crystallization steps, we have the expertise and capacity to meet your needs. Our technical team is available to discuss your specific requirements, provide sample COAs, and support your regulatory compliance efforts. Ready to optimize your supply chain? Reach out to our logistics team today for comprehensive specifications and tonnage availability.